Company intelligence / Profile preview

H2envirO

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

H2O Therapeutics is a digital therapeutics company focused on developing wearable-based solutions for neurological and chronic conditions. The company's flagship product, Parky, is an FDA-cleared mobile application that uses Apple Watch data to monitor tremors and dyskinesia in patients with Parkinson's disease. By providing real-time, objective data to clinicians, H2O Therapeutics aims to improve treatment management and patient outcomes through continuous monitoring. The company leverages advanced data analytics and wearable technology to bridge the gap between clinical visits and daily patient life.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Apple

Beyond the preview

Go deeper on H2envirO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H2envirO.

Explore the full profile